These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 28965013

  • 1. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
    Zhou Z, Liu Y, Ma M, Chang L.
    Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
    [Abstract] [Full Text] [Related]

  • 2. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
    Ma J, Huang X, Li Z, Shen Y, Lai J, Su Q, Zhao J, Xu J.
    J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. SDC4 Gene Silencing Favors Human Papillary Thyroid Carcinoma Cell Apoptosis and Inhibits Epithelial Mesenchymal Transition via Wnt/β-Catenin Pathway.
    Chen LL, Gao GX, Shen FX, Chen X, Gong XH, Wu WJ.
    Mol Cells; 2018 Sep 30; 41(9):853-867. PubMed ID: 30165731
    [Abstract] [Full Text] [Related]

  • 5. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling.
    Wang X, Lu X, Geng Z, Yang G, Shi Y.
    J Cell Biochem; 2017 Dec 30; 118(12):4745-4752. PubMed ID: 28513866
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. LINC00958/miR-627 signal axis regulates the proliferation, migration, and invasion of thyroid papillary carcinoma cells by TRIM44.
    Li YQ, Wang LC, Li AX, Huang W, Song Y, Wang W.
    Kaohsiung J Med Sci; 2022 May 30; 38(5):415-424. PubMed ID: 35199939
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic potential of Dickkopf-1 in wild-type BRAF papillary thyroid cancer via regulation of β-catenin/E-cadherin signaling.
    Cho SW, Kim YA, Sun HJ, Ahn HY, Lee EK, Yi KH, Oh BC, Park DJ, Cho BY, Park YJ.
    J Clin Endocrinol Metab; 2014 Sep 30; 99(9):E1641-9. PubMed ID: 24848709
    [Abstract] [Full Text] [Related]

  • 9. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.
    Wen D, Liao T, Ma B, Qu N, Shi RL, Lu ZW, Wang YL, Wei WJ, Ji QH.
    Cancer Med; 2018 Feb 30; 7(2):285-296. PubMed ID: 29341469
    [Abstract] [Full Text] [Related]

  • 10. Knockdown of SOX9 Inhibits the Proliferation, Invasion, and EMT in Thyroid Cancer Cells.
    Huang J, Guo L.
    Oncol Res; 2017 Jan 26; 25(2):167-176. PubMed ID: 28277188
    [Abstract] [Full Text] [Related]

  • 11. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
    Zhang X, Li M, Zuo K, Li D, Ye M, Ding L, Cai H, Fu D, Fan Y, Lv Z.
    J Clin Endocrinol Metab; 2013 Aug 26; 98(8):E1305-13. PubMed ID: 23796566
    [Abstract] [Full Text] [Related]

  • 12. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.
    Qiu W, Yang Z, Fan Y, Zheng Q.
    Tumour Biol; 2016 Sep 26; 37(9):12665-12672. PubMed ID: 27448298
    [Abstract] [Full Text] [Related]

  • 13. FOXN3 suppresses the growth and invasion of papillary thyroid cancer through the inactivation of Wnt/β-catenin pathway.
    Zhao C, Mo L, Li C, Han S, Zhao W, Liu L.
    Mol Cell Endocrinol; 2020 Sep 15; 515():110925. PubMed ID: 32619584
    [Abstract] [Full Text] [Related]

  • 14. Upregulation of TRIB2 by Wnt/β-catenin activation in BRAFV600E papillary thyroid carcinoma cells confers resistance to BRAF inhibitor vemurafenib.
    Wang N, Wen J, Ren W, Wu Y, Deng C.
    Cancer Chemother Pharmacol; 2021 Jul 15; 88(1):155-164. PubMed ID: 33860836
    [Abstract] [Full Text] [Related]

  • 15. KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway.
    Zhong J, Lin R, Wang G, Lin L, Ruan S, Liu W.
    Tissue Cell; 2022 Apr 15; 75():101739. PubMed ID: 35066335
    [Abstract] [Full Text] [Related]

  • 16. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
    Li JY, Han C, Zheng LL, Guo MZ.
    Chin Med J (Engl); 2012 Oct 15; 125(19):3526-31. PubMed ID: 23044318
    [Abstract] [Full Text] [Related]

  • 17. Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway.
    Cui D, Zhao Y, Xu J.
    Biochimie; 2018 May 15; 148():1-11. PubMed ID: 29471001
    [Abstract] [Full Text] [Related]

  • 18. Taraxasterol inhibits TGF-β1-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt/β-catenin signaling.
    Zhu J, Li X, Zhang S, Liu J, Yao X, Zhao Q, Kou B, Han P, Wang X, Bai Y, Zheng Z, Xu C.
    Hum Exp Toxicol; 2021 Dec 15; 40(12_suppl):S87-S95. PubMed ID: 34219514
    [Abstract] [Full Text] [Related]

  • 19. CDK5RAP3 acts as a putative tumor inhibitor in papillary thyroid carcinoma via modulation of Akt/GSK-3β/Wnt/β-catenin signaling.
    Feng X, Jiang J, Sun L, Zhou Q.
    Toxicol Appl Pharmacol; 2022 Apr 01; 440():115940. PubMed ID: 35219640
    [Abstract] [Full Text] [Related]

  • 20. ANKRD22 knockdown suppresses papillary thyroid cell carcinoma growth and migration and modulates the Wnt/β-catenin signaling pathway.
    Wu Y, Chen W, Zhang B, Liu H.
    Tissue Cell; 2023 Oct 01; 84():102193. PubMed ID: 37586180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.